fda status bpc-157 compounding pharmacies 2026 Approval 2026: Clinical Trials Big news in peptide medicine!

Publication date: Sept

They're growing in popularity but it's important to understand that they are not yet FDA approved and more clinical research is needed

Sci Signal 8(406):ra125 Cai Y et al (2005) Identification of a new RTN3 transcript, RTN3-A1, and its distribution in adult mouse brain

Homocysteine and cardiovascular disease Observational studies indicate that even moderately elevated blood concentrations of homocysteine raise the risk of cardiovascular disease (CVD), although randomized controlled trials of homocysteine-lowering therapy have generally not translated to reductions in adverse cardiovascular outcomes (26, 27)